AABB

AABB is a not-for-profit association representing institutions and individuals working in transfusion medicine and biotherapies. #AABB26 #AABBcabp

[AABB @AABB]

Member registration is now open for the 2026 AABB Annual Meeting, Oct. 17–19 in Atlanta.

Join colleagues from across the blood and biotherapies field for three days of learning, networking and collaboration.

Register by July 21 to save up to $325: https://t.co/yhFNTmSlpN

[AABB @AABB]

A previous pregnancy may offer important clues about future risk in fetal and neonatal alloimmune thrombocytopenia.

A new study identified factors associated with severe neonatal thrombocytopenia, helping inform risk assessment and management: https://t.co/QfZGXFTCpl

[AABB @AABB]

A survey from the UK’s FAIR Steering Group suggests that individualized donor assessment is expanding the donor pool while maintaining blood safety. The survey found 7.5% of male donors identified as LGBTQ+, compared with 1.8% in 2014.

More from @NHSBT: https://t.co/CWQRSyDTdd

[AABB @AABB]

A phase 3 trial published in @NEJM found no significant difference in 30-day mortality between prehospital LTOWB and component therapy in severely injured trauma patients.

Findings may support greater flexibility in prehospital transfusion practice: https://t.co/MNkz66BhDb

[Joe Chaffin, MD @bloodbankguy]

The Blood Bank Guy Essentials Podcast is SO BACK! Check out “What’s So Scary About Obstetric Hemorrhage,” with Kerry O’Brien. PLUS, you can get free CE/CME credit through @AABB! So excited to be back!
https://t.co/QMnaR8lG53 #blooducation #pathboards

[AABB @AABB]

More than 40 infectious diseases have emerged since the 1970s, including HIV, COVID-19, Zika and West Nile virus.

How can blood operators prepare for “Disease X”?

Experts share lessons from past outbreaks in the latest issue of AABB News: https://t.co/gorhrH03yr

[AABB @AABB]

Would you want to be enrolled in a trauma study without consent if it could save your life?

New findings from Canada suggest that trust in prehospital care is high, but support for deferred or waived research consent is conditional.

Read the study: https://t.co/i1VYrVaHyf

[AABB @AABB]

On Monday, the National Academies of Sciences, Engineering and Medicine is hosting a webinar on ensuring continuity and resilience of the nation’s blood system. Speakers include Meghan Delaney, DO, MPH, and John Hagins. Register now: https://t.co/kenjuqajwn

[AABB @AABB]

New in #Transfusion:

Investigators at @VUMCHealth report that requests for directed blood donations based on COVID-19 vaccination status at their institution were linked to care delays and clinical deterioration.

Read more: https://t.co/u0PFWUJfrh

[AABB @AABB]

Prehospital transfusion is growing, and so is the need for consistency in safety, storage and documentation.

The ADaPT course from North American Rescue and @theTHORNetwork reflects how AABB standards are being applied in EMS settings.

[THOR_Network @theTHORnetwork]

ADaPT is coming.
A 3-day course on prehospital transfusion, trauma resuscitation, and readiness.
May 6–8, Las Vegas
https://t.co/EVkwiaWCVk @NARescue @AABB
#ADaPTCourse #EMS #THOR

[AABB @AABB]

Prehospital transfusion saves lives, but optimal strategies remain unclear.

The SWiFT trial, published in @NEJM, found no survival or massive transfusion advantage to whole blood versus component therapy in severe trauma.

More on the AABB Newsfeed: https://t.co/SuOsCCaRyS

[AABB @AABB]

Blood donors taking PrEP are currently deferred.

But some may donate without disclosing it.

As PrEP use grows, blood services are weighing a complex question:

Should donated blood be tested for antiretroviral drugs? https://t.co/y4ZjkRtlZq

[AABB @AABB]

Whole blood resuscitation is well studied in trauma. But what about non-trauma hemorrhage?

Researchers from @WakeForestMed examined 331 patients. The findings suggest whole blood can be safely used in severely hemorrhaging non-trauma patients.

👉 https://t.co/d2lGOKjq9Z

[AABB @AABB]

In a new @TheLancet correspondence, members of the @NATO Blood Panel urged civilian blood systems to assess their ability to deliver life-saving transfusions during large-scale emergencies.

Read more on the AABB Newsfeed: https://t.co/EwgQC3b3rL

[AABB @AABB]

New in #Transfusion:

A survey of inpatient providers at @UChicagoHospMed explores which factors clinicians prioritize when deciding whether to transfuse. Five of the seven top-ranked factors were hemoglobin-related.

Explore the findings: https://t.co/ogMWRXymUB

[AABB @AABB]

Can we make powerful #AML immunotherapies safer?

AABB Foundation Scholar Pietro Genovese, PhD, engineered donor stem cells to resist CAR-T therapy, enabling effective treatment in preclinical studies without damaging healthy tissue.

More: https://t.co/D6I2hIcyRX

[AABB @AABB]

As RhD-positive emergency transfusion becomes more common in pediatric trauma, alloimmunization and #HDFN considerations extend to RhD-negative girls.

A new #Transfusion article outlines a practical management framework: https://t.co/PyXuJfvJsW

[AABB @AABB]

A new study in @JAMANetworkOpen analyzes >40,000 platelet transfusions in neonates and children using REDS-IV-P Vein-to-Vein data, examining transfusion thresholds, platelet increments, and platelet and donor characteristics.

Read the AABB summary: https://t.co/qsOv4xOEvj

[AABB @AABB]

@DKalodimou We can't wait. ☺️

[AABB @AABB]

Thank you, @ADM_Christine, for highlighting the urgent need for blood donations. 🩸

Giving blood is a simple act that makes a big difference for patients in need of a transfusion.

Find a donor center near you: https://t.co/hkfO4iFZf0

[ADM Brian Christine, MD @ADM_Christine]

As a physician, I’ve seen how lifesaving donated blood can be. Right now, blood supplies are low, with some communities having only a one- to two-day supply.

I donated recently, and if you’re eligible, I hope you’ll join me. One donation can save up to three lives. Watch and learn how you can help.